Emmanuel Mougeotte is BIOSerenity’s new CEO
With a rich and diverse background in the fields of digital health and care-focused technologies, Emmanuel Mougeotte takes the helm of BIOSerenity — a leader in AI applied to the diagnosis of neurological and sleep disorders — with the mission to strengthen and drive the company’s growth strategy in end-to-end teleneurology systems and the generation of biomarkers based on the “Large Brain Model,” a unique foundational AI model developed by BIOSerenity.
Jean Schmitt, Managing Partner and President of Jolt Capital, comments: “We are delighted to welcome Emmanuel as the head of BIOSerenity. His background demonstrates recognized expertise in growing health and diagnostic software companies that serve healthcare professionals, structuring international organizations, and deploying innovative technological solutions. Emmanuel is the right person to lead BIOSerenity — an exemplary medtech company leveraging AI to change the lives of patients with neurological disorders, in France, across Europe, and, we hope, soon around the world.”
Emmanuel Mougeotte states: “I am truly honored to join BIOSerenity at such a pivotal moment in its development. Technological innovation applied to healthcare offers a unique opportunity to transform medical practices, improve the patient journey, and simplify the daily work of caregivers. I am convinced that BIOSerenity, thanks to its talent, expertise, and vision, has all the assets needed to establish itself as the European leader in neurological tele-diagnosis.”
His background :
· 55 years old, Emmanuel Mougeotte is a graduate of HEC Paris (1995), the École Polytechnique Fédérale de Lausanne (1993), and EURECOM (1993).
· He began his career in 1996 at Nortel Networks, where he spent nearly twelve years across France, Portugal, and the Netherlands, holding various management positions in telecommunications and customer services.
· In 2008, he joined Comverse Technology as Vice President of Customer Services, a role in which he oversaw European operations for two years.
· In 2010, he moved to Agfa HealthCare, where he successively led the e-health services business and then took responsibility for the Southern Europe region (France, Italy, Spain, Portugal, and Belgium). There, he led the digital transformation of hospital information systems and the deployment of large-scale medical imaging and data management solutions.
· From May 2020 to November 2023, he served as Chief Executive Officer of Dedalus France, a European leader in healthcare software, where he managed the post-merger integration of the French entities and structured the organization around three main areas: hospitals, medical biology, and radiology.
· In December 2023, he became Chief Executive Officer of CompuGroup Medical France (CGM), one of the world’s leading e-health companies. The company develops software and information systems for all stakeholders in the healthcare ecosystem, including medical practices, hospitals, laboratories, pharmacies, and insurance organizations.
About BIOSerenity
BIOSerenity, founded in 2014, is the French leader in electrophysiological diagnostics, performing more than 45,000 EEGs (electroencephalograms), 8,000 PSGs (polysomnographies), and 5,000 ECGs (electrocardiograms) each year. Its offering combines medical devices, a software platform, and AI algorithms, all designed and produced in France, integrated into an ecosystem of services for the benefit of physicians and patients. This unique end-to-end solution enables complex examinations to be performed and provides remote interpretation of signals in a timely manner, contributing to faster and more reliable clinical decisions.
As an expert in neurology, BIOSerenity has developed the Large Brain Model (LBM), a foundation model trained on more than ten years of EEG recordings. This database and AI platform give rise to decision support tools that improve the quality and speed of interpretation.
Among its flagship services, the long-term (72-hour) home EEG, unique in France, speeds up access to diagnosis when hospital slots are hardly available. In sleep medicine, BIOSerenity relies on a network of dedicated centers and specialized medical and paramedical teams to accelerate the diagnosis of sleep disorders and optimize patient referral.
This vertical integration - devices, software, AI, and medical services - supports continuous improvement in the care pathway, as well as faster and more reliable diagnosis.
[Nov. 12th 2025]